drugset / Trial / NCT01453296
Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects
RandomizedCrossoverTriple-blindTreatment
Summary
This study will investigate the effect of dosing paedeatric asthmatic subjects with GW642444, an orally inhaled long-acting agonist of the β2-adrenoceptor.
Timeline
- Start
- 2010-08
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Vilanterol | Other / unclassified | 25 ug | Inhaled |